Private Equity / Venture Capital at OrbiMed Advisors
Greater New York City Area
August 2012 to Present
Greater New York City Area
Lazard Freres & Co.
Investment Banking Analyst
June 2010 to July 2012
San Francisco Bay Area
Instream Partners LLC
Investment Banking Intern
June 2009 to December 2009
Flag Tree Capital
Private Equity Intern
June 2009 to September 2009
What company does Diyong Xu work for?
Diyong Xu works for OrbiMed Advisors
What is Diyong Xu's role at OrbiMed Advisors?
Diyong Xu is Private Equity
What industry does Diyong Xu work in?
Diyong Xu works in the Venture Capital & Private Equity industry.
Private Equity @ Focus on venture capital investments in biotech, pharma, medical device, diagnostics, and healthcare IT companies From August 2012 to Present (3 years 5 months) Greater New York City AreaInvestment Banking Analyst @ Focused on M&A, financing and strategic advisory for biotech, diagnostics and pharma clients in U.S., Japan and E.U. Transaction experience: - GSK's acquisition of Human Genome Sciences ($3.6 billion) - Miraca's acquisition of Caris Life Sciences ($725 million) - Sale of SeraCare Life Sciences to Linden Capital ($82 million) - Sale of Cellzome to GSK ($100 million) - Equity financings for MAP, ArQule, AVI BioPharma, Anadys and Exact Sciences ($220+ million) From June 2010 to July 2012 (2 years 2 months) San Francisco Bay AreaInvestment Banking Intern @ Investment Banking Intern. Responsibilities include: 1. Performed private company valuation, including DCF, public company comparables, relevant transactions and liquidation events analysis 2. Built merger/acquisition models 3. Explored potential IPO opportunities for the clients 4. Created Quarterly Microelectronics manufacturing industry report, capturing key growth and performance metrics for sector 5. Developed targeted VC/PE prospect lists for clients in medical devices, lithography, specialty chemicals, atomic force microscopy, electric design automation, automatic testing equipments and communication equipments industries From June 2009 to December 2009 (7 months) Private Equity Intern @ Private Equity Intern. Responsibilities include: 1. Performed company and corresponding industry research; created valuation analysis and LBO models 2. Generated industry reports on smart grid, healthcare, and information service industries to support deal sourcing efforts 3. Enhanced quality of prospective deals in pipeline through additional review and due diligence From June 2009 to September 2009 (4 months) M.S., Management Science and Engineering (Concentration: Finance and Economics) @ Stanford University From 2008 to 2010 M.S., Molecular and Cellular Biology @ Dartmouth College From 2005 to 2008 Bachelor of Science (B.S.), Biological Science @ Zhejiang University From 2000 to 2004 Diyong Xu is skilled in: Private Equity, Biotechnology, Healthcare, Venture Capital, Investment Banking, Pharmaceuticals, Diagnostics, LBO, Pharmaceutical Industry, DCF, Strategy, Finance, Mergers & Acquisitions, Due Diligence, Valuation, Equities, Hardware Diagnostics, Medical Devices
Introversion (I), Sensing (S), Thinking (T), Perceiving (P)
1 year(s), 7 month(s)
There's 95% chance that Diyong Xu is seeking for new opportunities
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 400K users from
76% of Fortune 500 companies
The most accurate data ever
Hire Anyone, Anywhere
with ContactOut today
Making remote or global hires? We can help.
No credit card required